Comparing the frequency of CD33 + pSTAT3 + myeloid‐derived suppressor cells and IL‐17 + lymphocytes in patients with prostate cancer and benign prostatic hyperplasia-Reference-Cited by-同舟云学术

Comparing the frequency of CD33 + pSTAT3 + myeloid‐derived suppressor cells and IL‐17 + lymphocytes in patients with prostate cancer and benign prostatic hyperplasia

Published:2021-06-29 Issue:10 Volume:45 Page:2086-2095
ISSN:1065-6995
Container-title:Cell Biology International
language:en
Short-container-title:Cell Biol Int

Author:

Sanaei Mohammad‐Javad¹,Taheri Fatemeh²,Heshmati Masoud¹,Bashash Davood³^ORCID,Nazmabadi Roya¹,Mohammad‐Alibeigi Faramarz⁴,Nahid‐Samiei Mahboobeh¹,Shirzad Hedayatollah¹,Bagheri Nader¹^ORCID

Affiliation:

1. Cellular and Molecular Research Center, Basic Health Sciences Institute Shahrekord University of Medical Sciences Shahrekord Iran

2. Department of Pathology Shahrekord University of Medical Sciences Shahrekord Iran

3. Department of Hematology and Blood Banking, School of Allied Medical Sciences Shahid Beheshti University of Medical Sciences Tehran Iran

4. Department of Urology Shahrekord University of Medical Sciences Shahrekord Iran

Funder

Shahrekord University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbin.11651

Reference53 articles.

1. Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients

2. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

3. Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison

4. The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer

5. T helper 17 cells play a critical pathogenic role in lung cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies;Cell Biochemistry and Function;2024-07

2. The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management;Cellular & Molecular Biology Letters;2024-05-14

3. Molecular mechanisms of Chengshi Beixie Fenqing Decoction based on network pharmacology: pivotal roles of relaxin signaling pathway and its associated target proteins against Benign prostatic hyperplasia;Journal of Biomolecular Structure and Dynamics;2023-04-27

4. STAT3 and Its Pathways’ Dysregulation—Underestimated Role in Urological Tumors;Cells;2022-09-27

5. Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer;Frontiers in Oncology;2022-07-04